Brief: Alpha Tau Medical Announces Full Year 2022 Financial Results
09/03/2023 21:11
March 9 (Reuters) - Alpha Tau Medical Ltd DRTS.O :
* ALPHA TAU MEDICAL ANNOUNCES FULL YEAR 2022 FINANCIAL
RESULTS AND
PROVIDES CORPORATE UPDATE
* ALPHA TAU MEDICAL LTD FY LOSS PER SHARE $0.53
* ALPHA TAU MEDICAL LTD - CASH & EQUIVALENTS BALANCE OF
$105.4
MILLION, WITH RUNWAY FOR AT LEAST TWO YEARS
Source text for Eikon: ID:nGNX1kwF4V
Further company coverage: DRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Tau Medical
See all newsBrief: Alpha Tau Completes Patient Enrollment In Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal Of FDA Approval Of Alpha Dart® To Treat Recurrent Cutaneous Squamous Cell Carcinoma
Brief: Alpha Tau Announces 100% Local Disease Control Rate And Favorable Safety Profile Observed In Alpha Dart® Pancreatic Cancer Trials Presented At Ddw 2026
Brief: Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing
Brief: Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026
Brief: Alpha Tau Medical Receives Japanese Marketing Approval For Alpha Dart In Head And Neck Cancer